SLIDESHOW: Future Dividend Aristocrats: Close Contenders
By Dividend Channel Staff, updated Fri, January 23, 8:26 PM
| This Slide: #2 of 25 |
#24. Amgen Inc (NASDAQ:AMGN) — 2.90% Yield, 14+ Years of Dividends
Amgen Inc. is a biotechnology company dedicated to discovering, developing, manufacturing, and delivering human therapeutics. It focuses on addressing high unmet medical needs to enhance health outcomes and improve lives. Operating primarily in the human therapeutics segment, Amgen's extensive portfolio includes well-known products such as Aranesp, ENBREL, Prolia, Neulasta, Otezla, and Repatha, among others. These therapies target various conditions, showcasing Amgen's commitment to leveraging its expertise in biotechnology to provide innovative solutions for patients.
View AMGN's Dividend History»
ETFs holding AMGN
|
Open the Dividend Channel AMGN Page (in a new window) »
AMGN Next Dividend Date » (Projection based upon history) AMGN Dividend Growth Rate » Quotes delayed 20 minutes |
Buy (2.76 out of 4) 65th percentile
(ranked higher than approx. 65% of all stocks covered)
Analysts' Target Price: AMGN Forecast Based on data provided by Zacks Investment Research via Quandl.com |
|
|